Iovance Biotherapeutics
IOVA
IOVA
248 hedge funds and large institutions have $2.6B invested in Iovance Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 109 increasing their positions, 65 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.16% less ownership
Funds ownership: 99.36% → 99.2% (-0.16%)
12% less capital invested
Capital invested by funds: $2.96B → $2.6B (-$366M)
Holders
248
Holding in Top 10
3
Calls
$41.7M
Puts
$7.48M
Top Buyers
| 1 | +$37.7M | |
| 2 | +$34.5M | |
| 3 | +$34M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$29.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$28.4M |
Top Sellers
| 1 | -$69.3M | |
| 2 | -$57.3M | |
| 3 | -$43.1M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$42.7M |
| 5 |
FM
Frazier Management
Seattle,
Washington
|
-$33.4M |